{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:45:29Z","timestamp":1793295929753,"version":"4.5.0"},"reference-count":50,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Numerous studies have provided evidence for the negative associations of the COVID-19 pandemic with mental health, but data on the use of psychotropic medication in children and adolescents after the onset of the COVID-19 pandemic are lacking.<\/jats:p><\/jats:sec>Objective<\/jats:title>To assess the rates and trends of psychotropic medication prescribing before and over the 2 years after the onset of the COVID-19 pandemic in children and adolescents in France.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cross-sectional study used nationwide interrupted time-series analysis of outpatient drug dispensing data from the IQVIA X-ponent database. All 8\u202f839\u202f143 psychotropic medication prescriptions dispensed to children (6 to 11 years of age) and adolescents (12 to 17 years of age) between January 2016 and May 2022 in France were retrieved and analyzed.<\/jats:p><\/jats:sec>Exposure<\/jats:title>Onset of COVID-19 pandemic.<\/jats:p><\/jats:sec>Main outcomes and Measures<\/jats:title>Monthly rates of psychotropic medication prescriptions per 1000 children and adolescents were analyzed using a quasi-Poisson regression before and after the pandemic onset (March 2020), and percentage changes in rates and trends were assessed. After the pandemic onset, rate ratios (RRs) were calculated between estimated and expected monthly prescription rates. Analyses were stratified by psychotropic medication class (antipsychotic, anxiolytic, hypnotic and sedative, antidepressant, and psychostimulant) and age group (children, adolescents).<\/jats:p><\/jats:sec>Results<\/jats:title>In total, 8\u202f839\u202f143 psychotropic medication prescriptions were analyzed, 5\u202f884\u202f819 [66.6%] for adolescents and 2\u202f954\u202f324 [33.4%] for children. In January 2016, the estimated rate of monthly psychotropic medication prescriptions was 9.9 per 1000 children and adolescents, with the prepandemic rate increasing by 0.4% per month (95% CI, 0.3%-0.4%). In March 2020, the monthly prescription rate dropped by 11.5% (95% CI, \u221217.7% to \u22124.9%). During the 2 years following the pandemic onset, the trend changed significantly, and the prescription rate increased by 1.3% per month (95% CI, 1.2%-1.5%), reaching 16.1 per 1000 children and adolescents in May 2022. Monthly rates of psychotropic medication prescriptions exceeded the expected rates by 11% (RR, 1.11 [95% CI, 1.08-1.14]). Increases in prescribing trends were observed for all psychotropic medication classes after the pandemic onset but were substantial for anxiolytics, hypnotics and sedatives, and antidepressants. Prescription rates rose above those expected for all psychotropic medication classes except psychostimulants (RR, 1.12 [95% CI, 1.09-1.15] in adolescents and 1.06 [95% CI, 1.05-1.07] in children for antipsychotics; RR, 1.30 [95% CI, 1.25-1.35] in adolescents and 1.11 [95% CI, 1.09-1.12] in children for anxiolytics; RR, 2.50 [95% CI, 2.23-2.77] in adolescents and 1.40 [95% CI, 1.30-1.50] in children for hypnotics and sedatives; RR, 1.38 [95% CI, 1.29-1.47] in adolescents and 1.23 [95% CI, 1.20-1.25] in children for antidepressants; and RR, 0.97 [95% CI, 0.95-0.98] in adolescents and 1.02 [95% CI, 1.00-1.04] in children for psychostimulants). Changes were more pronounced among adolescents than children.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>These findings suggest that prescribing of psychotropic medications for children and adolescents in France significantly and persistently increased after the COVID-19 pandemic onset. Future research should identify underlying determinants to improve psychological trajectories in young people.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.7965","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T15:01:37Z","timestamp":1713884497000},"page":"e247965","source":"Crossref","is-referenced-by-count":39,"title":["Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 Pandemic"],"prefix":"10.1001","volume":"7","author":[{"given":"Zaba","family":"Valtuille","sequence":"first","affiliation":[{"name":"Center of Clinical Investigations, Inserm CIC1426, Robert Debr\u00e9 University Hospital, APHP.Nord, Paris, France"},{"name":"Paris Cit\u00e9 University, EA7323 Perinatal and Pediatric Pharmacology and Therapeutic Assessment, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Acquaviva","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Robert Debr\u00e9 University Hospital, APHP.Nord, Paris Cit\u00e9 University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Trebossen","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Robert Debr\u00e9 University Hospital, APHP.Nord, Paris Cit\u00e9 University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim","family":"Ouldali","sequence":"additional","affiliation":[{"name":"Department of General Pediatrics, Pediatric Infectious Disease and Internal Medicine, Robert Debr\u00e9 University Hospital, APHP.Nord, Paris Cit\u00e9 University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Bourmaud","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Unit, Inserm CIC1426, Robert Debr\u00e9 University Hospital, APHP.Nord, Paris Cit\u00e9 University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Sclison","sequence":"additional","affiliation":[{"name":"Consulting Services & Analytics Department, IQVIA, Courbevoie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Gomez","sequence":"additional","affiliation":[{"name":"Consulting Services & Analytics Department, IQVIA, Courbevoie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Revet","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Toulouse University Hospital, Toulouse, France"},{"name":"CERPOP, UMR 1295, Inserm, Toulouse III - Paul Sabatier University, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Peyre","sequence":"additional","affiliation":[{"name":"Autism Reference Centre of Languedoc-Roussillon CRA-LR, Montpellier University Hospital, Montpellier, France"},{"name":"Excellence Centre for Autism and Neurodevelopmental disorders- CeAND, MUSE University, Montpellier, France"},{"name":"Universit\u00e9 Paris-Saclay, UVSQ, Inserm, CESP, Team DevPsy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Delorme","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Robert Debr\u00e9 University Hospital, APHP.Nord, Paris Cit\u00e9 University, Paris, France"},{"name":"Human Genetics & Cognitive Functions, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentia","family":"Kaguelidou","sequence":"additional","affiliation":[{"name":"Center of Clinical Investigations, Inserm CIC1426, Robert Debr\u00e9 University Hospital, APHP.Nord, Paris, France"},{"name":"Paris Cit\u00e9 University, EA7323 Perinatal and Pediatric Pharmacology and Therapeutic Assessment, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"issue":"4","key":"zoi240296r1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1017\/S2045796015001158","article-title":"The global coverage of prevalence data for mental disorders in children and adolescents.","volume":"26","author":"Erskine","year":"2017","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"9904","key":"zoi240296r2","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"zoi240296r3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamapsychiatry.2019.3523","article-title":"Incidence rates and cumulative incidences of the full spectrum of diagnosed mental disorders in childhood and adolescence.","volume":"77","author":"Dalsgaard","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"zoi240296r4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.8533","article-title":"US pediatric emergency department visits for mental health conditions during the COVID-19 pandemic.","volume":"4","author":"Krass","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi240296r5","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2021.6298","article-title":"Utilization of physician-based mental health care services among children and adolescents before and during the COVID-19 pandemic in Ontario, Canada.","volume":"176","author":"Saunders","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"10312","key":"zoi240296r6","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.","volume":"398","author":"Collaborators","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"zoi240296r7","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/pds.v31.10","article-title":"Core concepts in pharmacoepidemiology: measures of drug utilization based on individual-level drug dispensing data.","volume":"31","author":"Rasmussen","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"zoi240296r8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jad.2022.11.068","article-title":"Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia.","volume":"323","author":"Tiger","year":"2023","journal-title":"J Affect Disord"},{"issue":"6","key":"zoi240296r9","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1192\/bjp.2022.112","article-title":"Impact of the COVID-19 pandemic on psychotropic medication uptake: time-series analysis of a population-wide cohort.","volume":"221","author":"Maguire","year":"2022","journal-title":"Br J Psychiatry"},{"issue":"1","key":"zoi240296r10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13034-023-00584-0","article-title":"Primary care visits due to mental health problems and use of psychotropic medication during the COVID-19 pandemic in Finnish adolescents and young adults.","volume":"17","author":"Kuitunen","year":"2023","journal-title":"Child Adolesc Psychiatry Ment Health"},{"issue":"1","key":"zoi240296r11","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2022-100941","article-title":"Mental health-related healthcare service utilisation and psychotropic drug dispensation trends in British Columbia during COVID-19 pandemic: a population-based study.","volume":"36","author":"Zandy","year":"2023","journal-title":"Gen Psychiatr"},{"issue":"7","key":"zoi240296r12","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1017\/S0033291721004839","article-title":"Impact of COVID-19 pandemic and lockdowns on the consumption of anxiolytics, hypnotics and antidepressants according to age groups: a French nationwide study.","volume":"53","author":"Levaillant","year":"2023","journal-title":"Psychol Med"},{"issue":"1","key":"zoi240296r13","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s12889-023-15360-0","article-title":"Psychotropic consumption before and during COVID-19 in Asturias, Spain.","volume":"23","author":"Garc\u00eda","year":"2023","journal-title":"BMC Public Health"},{"issue":"10","key":"zoi240296r15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"issue":"9","key":"zoi240296r16","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1093\/jac\/dkab185","article-title":"Monitoring outpatient antibiotic utilization using reimbursement and retail sales data: a population-based comparison in France, 2012-17.","volume":"76","author":"Trinh","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"zoi240296r17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jpeds.2022.01.041","article-title":"Pediatric prescriptions of proton pump inhibitors in France (2009-2019): a time-series analysis of trends and practice guidelines impact.","volume":"245","author":"Yang","year":"2022","journal-title":"J Pediatr"},{"issue":"1","key":"zoi240296r19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/ije\/dyw098","article-title":"Interrupted time series regression for the evaluation of public health interventions: a tutorial.","volume":"46","author":"Bernal","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"4","key":"zoi240296r20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research.","volume":"27","author":"Wagner","year":"2002","journal-title":"J Clin Pharm Ther"},{"issue":"8","key":"zoi240296r21","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/sim.v42.8","article-title":"In praise of Prais-Winsten: an evaluation of methods used to account for autocorrelation in interrupted time series.","volume":"42","author":"Bottomley","year":"2023","journal-title":"Stat Med"},{"key":"zoi240296r22","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.jad.2023.08.070","article-title":"Impact of the COVID-19 pandemic on the mental health of children and adolescents: a systematic review and meta-analysis of longitudinal studies.","volume":"340","author":"Miao","year":"2023","journal-title":"J Affect Disord"},{"issue":"9","key":"zoi240296r23","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s00787-020-01672-8","article-title":"Evidence suggests children are being left behind in COVID-19 mental health research.","volume":"31","author":"Racine","year":"2022","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"6","key":"zoi240296r24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1001\/jamapediatrics.2023.0846","article-title":"Changes in depression and anxiety among children and adolescents from before to during the COVID-19 pandemic: a systematic review and meta-analysis.","volume":"177","author":"Madigan","year":"2023","journal-title":"JAMA Pediatr"},{"issue":"11","key":"zoi240296r25","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/jamapediatrics.2021.2482","article-title":"Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis.","volume":"175","author":"Racine","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"12","key":"zoi240296r26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.46548","article-title":"Hospitalizations associated with mental health conditions among adolescents in the US and France during the COVID-19 pandemic.","volume":"5","author":"Guti\u00e9rrez-Sacrist\u00e1n","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi240296r27","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-029280","article-title":"Suicide ideation and attempts in a pediatric emergency department before and during COVID-19.","volume":"147","author":"Hill","year":"2021","journal-title":"Pediatrics"},{"issue":"4","key":"zoi240296r28","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-052201","article-title":"Medical admissions among adolescents with eating disorders during the COVID-19 pandemic.","volume":"148","author":"Otto","year":"2021","journal-title":"Pediatrics"},{"issue":"9","key":"zoi240296r29","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1001\/jamapsychiatry.2023.2195","article-title":"Trends in acute care use for mental health conditions among youth during the COVID-19 pandemic.","volume":"80","author":"Overhage","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"zoi240296r30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5694\/mja2.v219.1","article-title":"Psychotropic medication prescribing for children and adolescents by general practitioners during the COVID-19 pandemic.","volume":"219","author":"Hardie","year":"2023","journal-title":"Med J Aust"},{"issue":"4","key":"zoi240296r31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/jech-2021-216732","article-title":"Prescription of anxiolytics, sedatives, hypnotics and antidepressants in outpatient, universal care during the COVID-19 pandemic in Portugal: a nationwide, interrupted time-series approach.","volume":"76","author":"Estrela","year":"2022","journal-title":"J Epidemiol Community Health"},{"issue":"2","key":"zoi240296r32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/jamapsychiatry.2022.4165","article-title":"Psychotropic medication use and psychiatric disorders during the COVID-19 pandemic among Danish children, adolescents, and young adults.","volume":"80","author":"Bliddal","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"zoi240296r33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/acps.v146.4","article-title":"Psychotropic medication use in pediatric population during COVID-19 pandemic.","volume":"146","author":"Kuitunen","year":"2022","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"zoi240296r34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jadohealth.2023.02.042","article-title":"A comparison of pediatric mental health diagnoses and selective serotonin reuptake inhibitor prescribing before and during the COVID-19 pandemic.","volume":"73","author":"Keares","year":"2023","journal-title":"J Adolesc Health"},{"key":"zoi240296r35","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jad.2022.08.119","article-title":"New prescription fills of selective serotonin reuptake inhibitors before and during the COVID-19 pandemic in Los Angeles County, California.","volume":"319","author":"Levin","year":"2022","journal-title":"J Affect Disord"},{"issue":"1","key":"zoi240296r36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5694\/mja2.v219.1","article-title":"Dispensing of psychotropic medications to Australian children and adolescents before and during the COVID-19 pandemic, 2013-2021: a retrospective cohort study.","volume":"219","author":"Wood","year":"2023","journal-title":"Med J Aust"},{"issue":"8","key":"zoi240296r37","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jaac.2022.12.026","article-title":"Data-driven assessment of adolescents\u2019 mental health during the COVID-19 pandemic.","volume":"62","author":"Bilu","year":"2023","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"zoi240296r38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13034-017-0192-1","article-title":"A multi-national comparison of antipsychotic drug use in children and adolescents, 2005-2012.","volume":"11","author":"Kalverdijk","year":"2017","journal-title":"Child Adolesc Psychiatry Ment Health"},{"issue":"2","key":"zoi240296r39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S2215-0366(22)00404-7","article-title":"Trends in antipsychotic prescribing to children and adolescents in England: cohort study using 2000-19 primary care data.","volume":"10","author":"Radojcic","year":"2023","journal-title":"Lancet Psychiatry"},{"issue":"20","key":"zoi240296r41","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1001\/jama.2023.18932","article-title":"Changes in employment in the US health care workforce, 2016-2022.","volume":"330","author":"Nguyen","year":"2023","journal-title":"JAMA"},{"issue":"9","key":"zoi240296r42","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S2352-4642(20)30177-2","article-title":"COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study.","volume":"4","author":"G\u00f6tzinger","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"issue":"9","key":"zoi240296r43","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamapsychiatry.2023.1298","article-title":"Addressing the mental health crisis in youth\u2014sick individuals or sick societies?","volume":"80","author":"Aftab","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"zoi240296r44","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.634909","article-title":"Cyberbullying among adolescents and children: a comprehensive review of the global situation, risk factors, and preventive measures.","volume":"9","author":"Zhu","year":"2021","journal-title":"Front Public Health"},{"key":"zoi240296r45","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jpeds.2021.04.071","article-title":"Children witnessing domestic and family violence: a widespread occurrence during the coronavirus disease 2019 (COVID-19) pandemic.","volume":"235","author":"Ferrara","year":"2021","journal-title":"J Pediatr"},{"issue":"8","key":"zoi240296r46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00787-021-01758-x","article-title":"The impact of school closure and social isolation on children in vulnerable families during COVID-19: a focus on children\u2019s reactions.","volume":"31","author":"Larsen","year":"2022","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"zoi240296r47","doi-asserted-by":"publisher","journal-title":"Eur Neuropsychopharmacol","DOI":"10.1016\/j.euroneuro.2016.02.001"},{"key":"zoi240296r48","doi-asserted-by":"publisher","journal-title":"Epidemiol Psychiatr Sci","DOI":"10.1017\/S2045796020000293"},{"key":"zoi240296r49","doi-asserted-by":"publisher","journal-title":"Lancet Psychiatry","DOI":"10.1016\/S2215-0366(22)00404-7"},{"key":"zoi240296r50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jad.2021.05.044","article-title":"Is the COVID-19 pandemic a risk factor for suicide attempts in adolescent girls?","volume":"292","author":"Gracia","year":"2021","journal-title":"J Affect Disord"},{"key":"zoi240296r14","unstructured":"Impact of the COVID-19 pandemic on mental health service utilization in children and adolescents. Updated February 23, 2024. Accessed March 20, 2024. ClinicalTrials.gov identifier: NCT05260866. https:\/\/clinicaltrials.gov\/study\/NCT05260866?term=NCT05260866&rank=1"},{"key":"zoi240296r18","unstructured":"Institut National de la Statistique et des \u00c9tudes \u00c9conomiques. Statistiques et \u00e9tudes. Accessed October 30, 2023. https:\/\/www.insee.fr\/fr\/statistiques?"},{"key":"zoi240296r40","unstructured":"ViDAL. TDAH: la prescription de m\u00e9thylph\u00e9nidate peut d\u00e9sormais \u00eatre initi\u00e9e en villexxxxxxxxx. Accessed October 30,2023. https:\/\/www.vidal.fr\/actualites\/27908-tdah-la-prescription-de-methylphenidate-peut-desormais-etre-initiee-en-villexxxxxxxxx.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2817866\/valtuille_2024_oi_240296_1713196838.11209.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T15:01:40Z","timestamp":1713884500000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2817866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.7965","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}